Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06430489
PHASE2

Treatment of Suicidal Ideation in the Emergency Department Using Nitrous Oxide

Sponsor: University Hospital, Tours

View on ClinicalTrials.gov

Summary

Suicide prevention is a major public health concern, with nearly 9,000 suicides and over 200,000 suicide attempts reported each year in France. Suicide attempts and suicidal ideation are among the most frequent reasons for emergency room visits and psychiatric hospitalizations. Although there is no approved pharmacological treatment for suicidal crises, some psychiatric treatments appear promising. Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has shown promising results in reducing suicidal ideation. However, its use is limited due to its side effects. Nitrous oxide, another NMDA receptor inhibitor commonly used in anesthesia and pain management, has demonstrated rapid antidepressant effects and few side effects. Given its rapid and lasting effects, nitrous oxide could swiftly alleviate suicidal ideation.

Official title: Treatment of Suicidal Ideation in the Emergency Department Using Nitrous Oxide - PROTORISC Pilote

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2024-06

Completion Date

2026-01

Last Updated

2024-06-07

Healthy Volunteers

No

Interventions

DRUG

Nitrous oxide

inhaled nitrous oxide (1 hour at 50% concentration)

DRUG

Medical air

inhaled medical air (1 hour)

Locations (1)

Psychiatric Emergencies

Tours, France